BECTON DICKINSON & CO·4

Jun 25, 10:16 AM ET

Garrison Michael David 4

4 · BECTON DICKINSON & CO · Filed Jun 25, 2026

Research Summary

AI-generated summary of this filing

Updated

Becton Dickinson EVP Michael Garrison Sells 1,100 Shares

What Happened
Michael D. Garrison, EVP and President, Medical Essentials & Biopharma at Becton Dickinson (BDX), sold 1,100 shares on June 24, 2026. The reported sale price was $145.66 per share, for a total transaction value of $160,226. The transaction is reported as an open market or private sale (code S).

Key Details

  • Transaction date and price: 2026-06-24 — 1,100 shares at $145.66 each.
  • Total value: $160,226.
  • Reported as: Open market or private sale (S).
  • Plan/footnote: Executed pursuant to a Rule 10b5‑1 trading plan adopted by the reporting person on February 18, 2026.
  • Filing date: Report filed 2026-06-25 for the 6/24 transaction (timely filing based on provided dates).
  • Shares owned after transaction: Not disclosed in the excerpt provided.

Context
A 10b5‑1 plan indicates the trades were prearranged and scheduled in advance, which commonly reduces the extent to which a sale is interpreted as a signal about company prospects. Sales by executives are routine for liquidity, diversification, or other personal reasons; purchases generally carry more weight for signaling. This report documents a standard insider sale under a preexisting plan.

Insider Transaction Report

Form 4
Period: 2026-06-24
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Transactions
  • Sale

    Common Stock

    2026-06-24$145.66/sh1,100$160,22613,172 total
Signature
Donna Kalazdy, by power of attorney from Michael David Garrison|2026-06-25

Documents

1 file
  • 4
    wk-form4_1782396959.xmlPrimary

    FORM 4